Research Topics
Species | Gabrielle L GoldbergSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantationGabrielle L Goldberg
Department of Pathology and Immunology, Central and Eastern Clinical School, Monash University, Melbourne, Australia
J Immunol 178:7473-84. 2007..These results indicate that sex steroid ablation can profoundly enhance thymic and hemopoietic recovery following allogeneic HSCT without increasing GVHD and maintaining GVT...
Sex steroid ablation enhances hematopoietic recovery following cytotoxic antineoplastic therapy in aged miceJarrod A Dudakov
Immune Regeneration Laboratory, Monash Immunology and Stem Cell Laboratories, Monash University, Wellington Road, Clayton VIC 3800, Australia
J Immunol 183:7084-94. 2009..Taken together, these results provide the basis for the use of SSA in the clinic to enhance treatment outcomes from cytotoxic antineoplastic therapy...
Sex steroid ablation enhances immune reconstitution following cytotoxic antineoplastic therapy in young miceGabrielle L Goldberg
Immune Regeneration Laboratory, Monash Immunology and Stem Cell Laboratories, Monash University, Clayton, Australia
J Immunol 184:6014-24. 2010..In conclusion, SSA enhances T cell recovery following cyclophosphamide treatment of mice, at the level of the thymocytes and their stromal niches. This provides a new approach to immune reconstitution following antineoplastic therapy...
Withdrawal of sex steroids reverses age- and chemotherapy-related defects in bone marrow lymphopoiesisJarrod A Dudakov
Immune Regeneration Laboratory, Monash Immunology and Stem Cell Laboratories, Monash University, Clayton, Australia
J Immunol 182:6247-60. 2009..Since SSA has been achieved clinically for over 25 years, this provides a novel, rational basis for approaching the need for immune recovery in many clinical conditions...
Sex steroid ablation enhances lymphoid recovery following autologous hematopoietic stem cell transplantationGabrielle L Goldberg
Department of Immunology, Central and Eastern Clinical School, Monash University, Melbourne, Australia
Transplantation 80:1604-13. 2005....
Effects of castration on thymocyte development in two different models of thymic involutionTracy S P Heng
Department of Immunology, Monash University, Central and Eastern Clinical School, Alfred Hospital, Prahran, Australia
J Immunol 175:2982-93. 2005..By improving our understanding of the kinetics of thymic recovery, this study will allow more appropriate timing of therapy to achieve maximal reconstitution, especially in the elderly...
Controlling the thymic microenvironmentDaniel H D Gray
Department of Immunology, Central and Eastern Clinical School, Monash University, Melbourne, 3181, Australia
Curr Opin Immunol 17:137-43. 2005..Elucidation of the molecular players involved and their context within the organ is the challenge for the field today. This knowledge could then be translated to clinical restoration of thymic function and T-cell reconstitution...
Keratinocyte growth factor (KGF) is required for postnatal thymic regenerationOnder Alpdogan
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Blood 107:2453-60. 2006..We conclude that KGF plays a critical role in postnatal thymic regeneration and may be useful in treating immune deficiency conditions...
Activation of thymic regeneration in mice and humans following androgen blockadeJayne S Sutherland
Department of Immunology, Monash University Medical School, Prahran, Victoria, Australia
J Immunol 175:2741-53. 2005..Collectively these studies represent a fundamentally new approach to treating immunodeficiency states in humans...
Clinical strategies to enhance T cell reconstitutionGabrielle L Goldberg
Department of Immunology, Laboratory of the Immunology of Bone Marrow Transplantation, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Semin Immunol 19:289-96. 2007....
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursorsJohannes L Zakrzewski
Department Immunology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Nat Biotechnol 26:453-61. 2008..We conclude that ex vivo generated MHC-disparate T-cell precursors from any donor can be used universally for 'off-the-shelf' immunotherapy, and can be further enhanced by genetic engineering for targeted immunotherapy...
Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trendsJohannes L Zakrzewski
Department of Medicine and Immunology, Memorial Sloan Kettering Cancer Center, Zuckerman Research Center, New York, NY 10021, USA
Blood Cells Mol Dis 40:44-7. 2008..The translation of most of these strategies into clinical trials is likely and in some cases Phase I/II studies are already underway...
